Two Sigma Investments
INAB icon

Two Sigma Investments’s IN8bio INAB Stock Holding History

Two Sigma Investments’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,214
Closed -$66K – 4742
2025
Q4 		$66K Sell
28,214
-21,239
-43% -$40.4K ﹤0.01% 3899
2025
Q3 		$107K Buy
+49,453
New +$109K ﹤0.01% 3458
2024
Q2 		– Sell
-1,384
Closed -$49K – 3170
2024
Q1 		$49K Sell
1,384
-27
-2% -$1.02K ﹤0.01% 2886
2023
Q4 		$58.4K Buy
+1,411
New +$45.1K ﹤0.01% 2984
2023
Q3 		– Sell
-606
Closed -$28K – 3072
2023
Q2 		$28K Buy
+606
New +$37.9K ﹤0.01% 2885

Other funds holding INAB

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Two Sigma Investments's INAB Position: Q1 2026 in Review

Two Sigma Investments sold out of IN8bio (INAB) in Q1 2026, closing a stake of 28,214 shares — an estimated $66K sold.

Two Sigma Investments first reported a position in INAB in Q2 2023 and held it in 5 quarters. The position peaked at $107K in Q3 2025. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.

  • Two Sigma Investments reported no remaining IN8bio position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 28,214 IN8bio shares in Q1 2026, an estimated $66K.
  • Two Sigma Investments first reported a position in IN8bio in Q2 2023 and held it in 5 quarters.
  • Two Sigma Investments's IN8bio position peaked at $107K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.